Multi-target kinase inhibitors: From data to practice
9 May 2019
Multi-target kinase inhibitors: From data to practice
EAU prostate cancer guidelines 2019: What changed and why?
Neoadjuvant treatment before radical prostatectomy: Current situation
Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy
First- and second-line treatments for locally advanced renal cell carcinoma
Surgical management of pancreatic cancer
Advanced HCC: New systemic treatment options
Highlights from IGILUC 2019
Quality of life and local treatment of oligometastatic prostate cancer
The Brain Tumour Charity
Current treatment for brain tumours
How the WIN consortium achieves its goals